Cargando…

Assessing the Severity of Traumatic Brain Injury—Time for a Change?

Traumatic brain injury (TBI) has been described to be man’s most complex disease, in man’s most complex organ. Despite this vast complexity, variability, and individuality, we still classify the severity of TBI based on non-specific, often unreliable, and pathophysiologically poorly understood measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenovuo, Olli, Diaz-Arrastia, Ramon, Goldstein, Lee E., Sharp, David J., van der Naalt, Joukje, Zasler, Nathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795933/
https://www.ncbi.nlm.nih.gov/pubmed/33406786
http://dx.doi.org/10.3390/jcm10010148
_version_ 1783634561784086528
author Tenovuo, Olli
Diaz-Arrastia, Ramon
Goldstein, Lee E.
Sharp, David J.
van der Naalt, Joukje
Zasler, Nathan D.
author_facet Tenovuo, Olli
Diaz-Arrastia, Ramon
Goldstein, Lee E.
Sharp, David J.
van der Naalt, Joukje
Zasler, Nathan D.
author_sort Tenovuo, Olli
collection PubMed
description Traumatic brain injury (TBI) has been described to be man’s most complex disease, in man’s most complex organ. Despite this vast complexity, variability, and individuality, we still classify the severity of TBI based on non-specific, often unreliable, and pathophysiologically poorly understood measures. Current classifications are primarily based on clinical evaluations, which are non-specific and poorly predictive of long-term disability. Brain imaging results have also been used, yet there are multiple ways of doing brain imaging, at different timepoints in this very dynamic injury. Severity itself is a vague concept. All prediction models based on combining variables that can be assessed during the acute phase have reached only modest predictive values for later outcome. Yet, these early labels of severity often determine how the patient is treated by the healthcare system at large. This opinion paper examines the problems and provides caveats regarding the use of current severity labels and the many practical and scientific issues that arise from doing so. The objective of this paper is to show the causes and consequences of current practice and propose a new approach based on risk classification. A new approach based on multimodal quantifiable data (including imaging and biomarkers) and risk-labels would be of benefit both for the patients and for TBI clinical research and should be a priority for international efforts in the field.
format Online
Article
Text
id pubmed-7795933
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77959332021-01-10 Assessing the Severity of Traumatic Brain Injury—Time for a Change? Tenovuo, Olli Diaz-Arrastia, Ramon Goldstein, Lee E. Sharp, David J. van der Naalt, Joukje Zasler, Nathan D. J Clin Med Review Traumatic brain injury (TBI) has been described to be man’s most complex disease, in man’s most complex organ. Despite this vast complexity, variability, and individuality, we still classify the severity of TBI based on non-specific, often unreliable, and pathophysiologically poorly understood measures. Current classifications are primarily based on clinical evaluations, which are non-specific and poorly predictive of long-term disability. Brain imaging results have also been used, yet there are multiple ways of doing brain imaging, at different timepoints in this very dynamic injury. Severity itself is a vague concept. All prediction models based on combining variables that can be assessed during the acute phase have reached only modest predictive values for later outcome. Yet, these early labels of severity often determine how the patient is treated by the healthcare system at large. This opinion paper examines the problems and provides caveats regarding the use of current severity labels and the many practical and scientific issues that arise from doing so. The objective of this paper is to show the causes and consequences of current practice and propose a new approach based on risk classification. A new approach based on multimodal quantifiable data (including imaging and biomarkers) and risk-labels would be of benefit both for the patients and for TBI clinical research and should be a priority for international efforts in the field. MDPI 2021-01-04 /pmc/articles/PMC7795933/ /pubmed/33406786 http://dx.doi.org/10.3390/jcm10010148 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tenovuo, Olli
Diaz-Arrastia, Ramon
Goldstein, Lee E.
Sharp, David J.
van der Naalt, Joukje
Zasler, Nathan D.
Assessing the Severity of Traumatic Brain Injury—Time for a Change?
title Assessing the Severity of Traumatic Brain Injury—Time for a Change?
title_full Assessing the Severity of Traumatic Brain Injury—Time for a Change?
title_fullStr Assessing the Severity of Traumatic Brain Injury—Time for a Change?
title_full_unstemmed Assessing the Severity of Traumatic Brain Injury—Time for a Change?
title_short Assessing the Severity of Traumatic Brain Injury—Time for a Change?
title_sort assessing the severity of traumatic brain injury—time for a change?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795933/
https://www.ncbi.nlm.nih.gov/pubmed/33406786
http://dx.doi.org/10.3390/jcm10010148
work_keys_str_mv AT tenovuoolli assessingtheseverityoftraumaticbraininjurytimeforachange
AT diazarrastiaramon assessingtheseverityoftraumaticbraininjurytimeforachange
AT goldsteinleee assessingtheseverityoftraumaticbraininjurytimeforachange
AT sharpdavidj assessingtheseverityoftraumaticbraininjurytimeforachange
AT vandernaaltjoukje assessingtheseverityoftraumaticbraininjurytimeforachange
AT zaslernathand assessingtheseverityoftraumaticbraininjurytimeforachange